EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Updates in the Use of Targeted Therapies for Gynecologic Cancers

Evelyn Cantillo, Felix Blanc-Durand, Alexandra Leary, Brian M Slomovitz iD, Katherine Fuh, Christina Washington

American Society of Clinical Oncology Educational Book · 2024

DOI: 10.1200/edbk_438582 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2024. Verfasst von Evelyn Cantillo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicine, New York, NY. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Molecular Targeted Therapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted therapies have changed the treatment landscape in gynecologic cancer. Studies released over the past year have led to the incorporation of immunotherapy (IO) into the treatment for all patients with endometrial and cervical cancers at some point during their disease course. Poly(ADP-ribose) polymerase (PARP) inhibitors continue to play a role in women with ovarian carcinoma, particularly in homologous repair deficient tumors. Furthermore, the benefit of PARP inhibitors in challenging subgroups continues to be elucidated. Biomarker identification has led to the approval or compendium listing of several antibody-drug conjugates (ADCs). This review will update on IO, ADCs, and PARP inhibition for the treatment of gynecologic cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genital Neoplasms, FemaleMolecular Targeted TherapyHumansFemalePoly(ADP-ribose) Polymerase InhibitorsImmunotherapyImmunoconjugatesAntineoplastic Agents

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsImmunoconjugatesAntineoplastic Agents

Autor:innen und Institutionen

  • Weill Cornell Medicine, New York, NY.
  • Institut Gustave Roussy, Paris, France.
  • Mount Sinai Medical Center, Miami, FL.
  • University of California, San Francisco, San Francisco, CA.
  • University of Oklahoma, Oklahoma City, OK.

ORCID-Profile: Brian M Slomovitz

Zitieren

APA

Cantillo, E., Blanc-Durand, F., Leary, A., Slomovitz, B. M., Fuh, K., & Washington, C. (2024). Updates in the Use of Targeted Therapies for Gynecologic Cancers. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_438582

Vancouver

Cantillo E, Blanc-Durand F, Leary A, Slomovitz BM, Fuh K, Washington C. Updates in the Use of Targeted Therapies for Gynecologic Cancers. American Society of Clinical Oncology Educational Book. 2024. doi:10.1200/edbk_438582

BibTeX
@article{Cantillo2024,
  author = {Cantillo, Evelyn and Blanc-Durand, Felix and Leary, Alexandra and Slomovitz, Brian M and Fuh, Katherine and Washington, Christina},
  title = {Updates in the Use of Targeted Therapies for Gynecologic Cancers},
  journal = {American Society of Clinical Oncology Educational Book},
  year = {2024},
  doi = {10.1200/edbk_438582}
}
Kostenlos starten →